Jeffrey D. Bloss

3.4k total citations · 1 hit paper
36 papers, 2.5k citations indexed

About

Jeffrey D. Bloss is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Jeffrey D. Bloss has authored 36 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Obstetrics and Gynecology, 13 papers in Reproductive Medicine and 12 papers in Surgery. Recurrent topics in Jeffrey D. Bloss's work include Endometrial and Cervical Cancer Treatments (18 papers), Ovarian cancer diagnosis and treatment (12 papers) and Cervical Cancer and HPV Research (8 papers). Jeffrey D. Bloss is often cited by papers focused on Endometrial and Cervical Cancer Treatments (18 papers), Ovarian cancer diagnosis and treatment (12 papers) and Cervical Cancer and HPV Research (8 papers). Jeffrey D. Bloss collaborates with scholars based in United States and United Kingdom. Jeffrey D. Bloss's co-authors include Jeffrey G. Bell, Virginia L. Brunetto, Mitchell Maiman, Nick M. Spirtos, Henry Keys, Andrew Pearlman, James A. Roberts, Richard J. Zaino, Philip J. DiSaia and Michael L. Berman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Jeffrey D. Bloss

35 papers receiving 2.4k citations

Hit Papers

A phase III trial of surgery with or without adjunctive e... 2004 2026 2011 2018 2004 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
    2004 1.2k citations Henry Keys, James A. Roberts et al. Gynecologic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey D. Bloss United States 19 1.8k 1.4k 699 660 328 36 2.5k
J.G. Aalders Netherlands 22 1.4k 0.8× 1.2k 0.9× 743 1.1× 713 1.1× 453 1.4× 64 2.5k
Nobuhiro Takeshima Japan 30 1.5k 0.8× 1.3k 0.9× 563 0.8× 673 1.0× 429 1.3× 153 2.4k
H Beerman Netherlands 17 2.1k 1.2× 1.7k 1.2× 578 0.8× 424 0.6× 365 1.1× 46 2.8k
C. Lhommé France 30 1.2k 0.7× 1.4k 1.0× 505 0.7× 940 1.4× 677 2.1× 147 2.8k
Jan G. Aalders Netherlands 21 979 0.6× 971 0.7× 501 0.7× 635 1.0× 278 0.8× 29 1.8k
R.R. Barakat United States 28 1.6k 0.9× 2.0k 1.4× 383 0.5× 980 1.5× 425 1.3× 60 2.8k
M. van Lent Netherlands 18 2.6k 1.4× 3.1k 2.1× 465 0.7× 1.3k 2.0× 528 1.6× 35 3.9k
George J. Olt United States 16 941 0.5× 902 0.6× 363 0.5× 680 1.0× 767 2.3× 38 2.3k
Andrea Maneo Italy 19 2.2k 1.3× 1.3k 0.9× 1.2k 1.8× 986 1.5× 621 1.9× 44 2.9k
Suk‐Joon Chang South Korea 22 1.3k 0.7× 1.6k 1.1× 326 0.5× 1.1k 1.6× 374 1.1× 135 2.3k

Countries citing papers authored by Jeffrey D. Bloss

Since Specialization
Citations

This map shows the geographic impact of Jeffrey D. Bloss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey D. Bloss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey D. Bloss more than expected).

Fields of papers citing papers by Jeffrey D. Bloss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey D. Bloss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey D. Bloss. The network helps show where Jeffrey D. Bloss may publish in the future.

Co-authorship network of co-authors of Jeffrey D. Bloss

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey D. Bloss. A scholar is included among the top collaborators of Jeffrey D. Bloss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey D. Bloss. Jeffrey D. Bloss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blagden, Sarah P., Stefan N. Symeonides, In Hwa Um, et al.. (2023). Abstract C032: NUC-7738 in combination with pembrolizumab in patients with metastatic melanoma: Phase 2 results from the NuTide:701 study. Molecular Cancer Therapeutics. 22(12_Supplement). C032–C032.
2.
Moore, David H., Chunqiao Tian, Bradley J. Monk, et al.. (2009). Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: A Gynecologic Oncology Group Study. Gynecologic Oncology. 116(1). 44–49. 115 indexed citations
3.
Keys, Henry, James A. Roberts, Virginia L. Brunetto, et al.. (2004). A Phase III Trial of Surgery With or Without Adjunctive External Pelvic Radiation Therapy in Intermediate-Risk Endometrial Adenocarcinoma: A Gynecologic Oncology Group Study. Obstetrical & Gynecological Survey. 59(7). 516–518. 77 indexed citations
4.
Keys, Henry, James A. Roberts, Virginia L. Brunetto, et al.. (2004). A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecologic Oncology. 92(3). 744–751. 1217 indexed citations breakdown →
5.
Miller, David S., John A. Blessing, Steven Waggoner, et al.. (2004). Phase II evaluation of 9-aminocamptothecin (9-AC, NSC #603071) in platinum-resistant ovarian and primary peritoneal carcinoma: A Gynecologic Oncology Group Study. Gynecologic Oncology. 96(1). 67–71. 17 indexed citations
6.
Mutch, David G. & Jeffrey D. Bloss. (2003). Gemcitabine in cervical cancer. Gynecologic Oncology. 90(2). S8–S15. 33 indexed citations
7.
DiSaia, Philip J. & Jeffrey D. Bloss. (2003). Treatment of ovarian cancer: new strategies. Gynecologic Oncology. 90(2). S24–S32. 58 indexed citations
8.
9.
Bloss, Jeffrey D.. (2001). Chemotherapy for advanced or recurrent carcinoma of the cervix. Current Oncology Reports. 3(1). 33–40. 2 indexed citations
10.
Rodabaugh, Kerry J. & Jeffrey D. Bloss. (2001). Breast Cancer Prevention. Clinical Obstetrics & Gynecology. 44(3). 478–484. 2 indexed citations
11.
12.
Bloss, Jeffrey D., et al.. (1995). A Retrospective Study of Tamoxifen and Endometrial Cancer in Breast Cancer Patients. Gynecologic Oncology. 59(2). 186–190. 38 indexed citations
13.
Bloss, Jeffrey D., Shu‐Yuan Liao, Richard E. Buller, et al.. (1993). Extraovarian Peritoneal Serous Papillary Carcinoma: A Case-Control Retrospective Comparison to Papillary Adenocarcinoma of the Ovary. Gynecologic Oncology. 50(3). 347–351. 183 indexed citations
14.
Anton‐Culver, Hoda, Jeffrey D. Bloss, Deborah Bringman, et al.. (1992). Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: A population-based epidemiologic study. American Journal of Obstetrics and Gynecology. 166(5). 1507–1514. 60 indexed citations
15.
Bloss, Jeffrey D., et al.. (1992). Bulky stage IB cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy. Gynecologic Oncology. 47(1). 21–27. 40 indexed citations
16.
Bloss, Jeffrey D., et al.. (1991). Use of vaginal hysterectomy for the management of stage I endometrial cancer in the medically compromised patient. Gynecologic Oncology. 40(1). 74–77. 68 indexed citations
17.
Bloss, Jeffrey D., Philip J. DiSaia, Robert S. Mannel, et al.. (1991). Radiation myelitis: A complication of concurrent cisplatin and 5-fluorouracil chemotherapy with extended field radiotherapy for carcinoma of the uterine cervix. Gynecologic Oncology. 43(3). 305–307. 11 indexed citations
18.
19.
Bloss, Jeffrey D., et al.. (1990). Hemolytic-uremic syndrome associated with neoadjuvant chemotherapy in the treatment of advanced cervical cancer. Gynecologic Oncology. 39(2). 214–217. 6 indexed citations
20.
Bloss, Jeffrey D., Gary D.V. Hankins, John C. Hauth, & Larry C. Gilstrap. (1987). The effect of oxytocin infusion on the pharmacokinetics of intramuscular magnesium sulfate therapy. American Journal of Obstetrics and Gynecology. 157(1). 156–160. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.G. Aalders Breakdown of academic impact, for papers by Nobuhiro Takeshima Breakdown of academic impact, for papers by H Beerman Breakdown of academic impact, for papers by C. Lhommé Breakdown of academic impact, for papers by Jan G. Aalders Breakdown of academic impact, for papers by R.R. Barakat Breakdown of academic impact, for papers by M. van Lent Breakdown of academic impact, for papers by George J. Olt Breakdown of academic impact, for papers by Andrea Maneo Breakdown of academic impact, for papers by Suk‐Joon Chang
Rankless by CCL
2026